CD274 and neoplasm: To evaluate the regulatory effect of bisecting GlcNAc on immunotherapy in vivo (Fig. 7A), we constructed 4T1 and EO771 tumor-bearing mice and treated them with forskolin, alone or in combination with anti-PD-L1 monoclonal antibody (PD-L1 mAb ).